How Long Do You Stay on Mounjaro for Weight Loss?

Does Mounjaro have a maximum treatment length?

The short answer is no, not in the way that some people expect when they start. Unlike NICE's recommendation for Wegovy (semaglutide), which sets a two-year ceiling for use within NHS specialist services, NICE's appraisal of tirzepatide (TA1026) does not impose a maximum duration. The guidance does say that if you haven't lost at least 5% of your body weight after six months at your highest tolerated dose, continuing treatment should be reviewed and may not be appropriate. But for people who are responding well, the expectation built into the appraisal is long-term use, because that reflects the biology involved.

Weight is regulated by hormones, gut signals and set-point mechanisms, not willpower. Tirzepatide works by activating two receptors (GIP and GLP-1) that reduce appetite and slow gastric emptying. When treatment stops, those effects stop too. Studies in the SURMOUNT programme, which enrolled thousands of adults, showed that participants who discontinued tirzepatide regained a substantial portion of their lost weight within a year. That is not a failure of the medicine; it is what the evidence shows about how weight biology works. Duration planning needs to account for it.

If you want a fuller picture of how long you can be on Mounjaro, the clinical and regulatory picture is more nuanced than a simple number of months.

When do people typically stop, and what happens?

Some people reach a stable maintenance weight and, in discussion with their prescriber, taper down or stop. Others continue indefinitely because their weight-related health conditions (high blood pressure, type 2 diabetes, obstructive sleep apnoea) require sustained management. The decision to stop is rarely a diary date. It tends to be a clinical milestone: weight is stable, lifestyle changes are embedded, and the prescriber judges the risk-benefit balance has shifted.

What the data from SURMOUNT-1 (72 weeks, published in the New England Journal of Medicine) showed was an average body-weight reduction of around 20–21% at the 15mg dose, numbers that took the full 72 weeks to accumulate. Stopping at, say, 16 weeks would mean leaving most of that potential on the table, and the risk of regain would kick in almost immediately.

There is also the question of what how long Mounjaro takes to work actually means in practice. Early weeks are about tolerability and dose titration, not maximum effect. Judging treatment duration from the first few months is like leaving a marathon at mile three.

How long do you have to stay on Mounjaro to keep the weight off?

This is the question our prescribers hear most often once people have been on treatment for six months or so. The honest answer: current evidence does not support a short course model for sustained weight loss. Studies looking at what happens after stopping (the SURMOUNT-5 trial and extension data) confirm the pattern seen with other GLP-1 medicines: weight returns, and in many cases returns to near the starting point within 12 months of discontinuation.

That does not mean you are committed to injections forever. It does mean that any plan to stop should be gradual, supported, and timed when your weight is stable and lifestyle foundations are solid. Some people manage well after stopping; others find their weight and health markers drift back and choose to restart. Both are legitimate clinical paths, and how long you need to stay on Mounjaro is something to revisit with your prescriber regularly rather than decide once at the start.

If you are on a private route, cost is a real factor in that conversation. You can see current treatment options and pricing on our treatment page, it is worth understanding what is included in your monthly cost before planning a multi-year timeline.

How does ongoing clinical review work at a private pharmacy like nume?

At nume, there are no standing repeats. Every supply requires a fresh clinical review by a GPhC-registered Independent Prescriber, a real person reads your update before your next pen is dispensed. That means if something changes (your weight plateaus, you develop a new condition, you want to discuss tapering), that conversation happens as part of the normal process rather than having to chase a separate appointment.

Our prescribers follow the same evidence base described above. If you are making good progress at your current dose, treatment continues. If progress stalls at your highest tolerated dose for six months, the guidance says that is the point to reassess, and that is exactly the kind of conversation that happens at review. Orders placed by midday Monday to Friday are reviewed the same day; if approved, your pen ships the same day via DPD, arriving the next working morning in plain packaging, practical timing if you plan around a busy week.

For a broader look at what treatment involves from the first week onwards, the Mounjaro overview on our site covers how the medicine works, the titration schedule, and what to expect along the way. The question of long-term duration sits within that wider picture, and it is one worth exploring before you start, not after six months in.